Intra-Cellular Therapies
Developing innovative medicines for the treatment of neuropsychiatric and neurodegenerative diseases
759 employees · est. 2002 · New York, United States
Intra-Cellular Therapies is the older company (2019 vs 2002); Intra-Cellular Therapies is the larger of the two.
Side-by-Side Comparison
| Metric | EpiHeart | Intra-Cellular Therapies |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2002 older |
| Headquarters | ||
| Headquarters | Helsinki, Finland | New York, United States |
| Employees | ||
| Employees | 5 | 759 larger |
| Industry | ||
| Industry | Health Care, Manufacturing | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post Ipo Debt |
| Total Funding | ||
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 9 |
| Services | ||
| Services | Cardiac Micrograft Therapy, Development of advanced cardiac cell therapies, Clinical study collaboration | Not tracked yet |
| Target Customers | ||
| Target Customers | Cardiac surgery units, Research institutions, Medical distributors, Healthcare professionals specializing in cardiac care | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cardiac Cellular Therapy, Medical Device Company, Ischemic Injury Repair, CABG, LVAD Surgery, Heart Failure Treatment, Cellular And Gene Therapies, Ischemic Cardiac Scars, Surgical Administration, Cardiac Treatment Innovation, Novel Therapies, Cardiac Surgery Integration | Not tracked yet |
| Website | ||
| Website | epiheart.com | intracellulartherapies.com |
About EpiHeart
EpiHeart, founded in 2019 and based in Finland, is a promising player in the Health Care and Manufacturing sectors. Their focus is clear: enabling surgical administration of cutting-edge cellular and gene therapies aimed particularly at cardiac care. Their innovation seeks to address significant ch...
About Intra-Cellular Therapies
Intra-Cellular Therapies, Inc. is a biopharmaceutical company founded on Nobel prize-winning research that allows it to understand how therapies affect the inner-workings of cells in the body. The Company leverages this intracellular approach to deliver innovative treatments for people living with c...
We will tell you when either one moves
BounceWatch watches EpiHeart and Intra-Cellular Therapies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at EpiHeart and Intra-Cellular Therapi... — by email.
Frequently Asked Questions
Compare EpiHeart with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at EpiHeart on 13 Nov 2025, and Intra-Cellular Therapies on 28 Oct 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
